Mastering CMC for Biologics From IND to BLAPublished 7/2026
MP4 |
Video: h264, 1920x1080 |
Audio: AAC, 44.1 KHz, 2 Ch
Language: English |
Duration: 6h 17m |
Size: 2.97 GB
Learn Biologics CMC, CTD Module 3, regulatory strategy, comparability, and global IND, BLA, MAA, and JNDA submissions.
What you'll learnDevelop complete CMC regulatory strategies for biologics from IND/IMPD through BLA, MAA, and JNDA submissions.
Author and critically review CTD Module 3 (Quality) for biologics, including drug substance, drug product).
Design scientifically justified control strategies, comparability plans, process validation, and lifecycle management approaches.
Prepare regulatory briefing packages, respond to health authority questions, and provide practical CMC consulting using real-world examples.
Gain a comprehensive understanding of types of biologics , development, integrated control strategy, process changes, comparability, and lifecycle management.
Learn CMC and regulatory
Requirements for biosimilars, including analytical similarity, comparability, and global regulatory expectations.
Develop the knowledge and confidence to work in Biologics CMC and Regulatory Affairs across development, submission, and lifecycle management.
RequirementsA basic understanding of pharmaceuticals, biotechnology, life sciences, chemistry, pharmacy, or a related scientific field is helpful but not mandatory.
No prior regulatory affairs experience is required; all fundamental concepts are explained before advancing to complex topics.
Willingness to learn biologics CMC, regulatory strategy, and global submission
Requirements.
A computer or tablet for viewing lectures and downloading course resources.
Pharma Students or professional with experience in Regulatory Affairs, Quality, Manufacturing, Analytical Development, Process Development, Validation, or Project Management will gain advanced practical insights.
DescriptionBiologics are among the fastest-growing areas of the pharmaceutical industry, yet CMC (Chemistry, Manufacturing, and Controls) remains one of the most challenging disciplines to master. This comprehensive course provides a practical, industry-focused understanding of biologics CMC from early development through commercial approval.
Unlike courses that simply summarize guidelines, this program explains the scientific rationale behind regulatory expectations using real-world examples, development scenarios, and practical CMC strategies. Each topic is presented in a structured and easy-to-follow manner, making complex regulatory concepts understandable and directly applicable to daily work.
Throughout the course, you will gain a comprehensive understanding of biologics development, including cell line development, cell banking, upstream and downstream manufacturing, analytical characterization, formulation development, fill-finish, viral safety, stability, process validation, integrated control strategy, Quality by Design (QbD), process changes, comparability, lifecycle management, and global regulatory
Requirements.
You will also learn how to prepare and critically review CTD Module 3 for IND, IMPD, BLA, MAA, and JNDA submissions, develop effective regulatory strategies, prepare briefing packages, and respond to health authority questions from agencies such as FDA, EMA, and PMDA.
The course includes dedicated coverage of biosimilars, explaining analytical similarity, regulatory expectations, and CMC development considerations.
Whether you are beginning a career in Biologics CMC or looking to strengthen your expertise as an experienced regulatory professional, this course provides practical knowledge that can be immediately applied in the pharmaceutical and biotechnology industry.
By the end of this course, you will have the confidence to contribute effectively to biologics CMC development, global regulatory submissions, dossier review, and regulatory strategy discussions.
Who this course is forPharmacists, biotechnology, pharmaceutical and life science students who want to build expertise in biologics CMC and global regulatory submissions.
Regulatory Affairs professionals working in biologics, biosimilars, vaccines, cell and gene therapy, or advanced biologic products.
Scientists and professionals in CMC, Manufacturing, Process Development, Analytical Development, Quality Assurance, Quality Control, and Validation, Supply chain Management
Experienced CMC professionals seeking practical knowledge on CTD Module 3, global regulatory strategy, comparability, control strategy, and lifecycle management
Professionals preparing for or transitioning into Biologics CMC, Regulatory Affairs, Technical Operations, or CMC consulting roles.
Recommend Download Link Hight Speed | Please Say Thanks Keep Topic Live
No Password - Links are Interchangeable
Cantinho Satkeys
